Kavita is a Principal1 of the firm and has been practicing pharmaceutical patent law, particularly in the area of litigation, since 2003. Kavita has extensive experience in proceedings under the Patented Medicines (Notice of Compliance) Regulations (on behalf of both innovators and generics) as well as patent actions and judicial reviews.
Kavita’s practice includes litigation management, preparation of expert evidence and both oral and written advocacy. Kavita has appeared frequently before the Federal Court and the Federal Court of Appeal. Her practice also includes invalidity and infringement opinions and advising on a variety of regulatory matters. In addition to being a lawyer, Kavita is a registered Canadian Patent Agent2 and holds a Ph.D. in Toxicology. She is recognized in various legal directories and was named one of the Top 250 Women in IP globally. Kavita is a frequent speaker on IP and litigation topics.
1 Practicing through a professional corporation.
2 Class 4, 2024
- Called to the Ontario Bar, 2003
- Registered Canadian Patent Agent, 2007 (Class 4, 2024)
- Registered Canadian Trade-Mark Agent, 2004 (Class 4, 2024)
- LLB, University of Western Ontario
- Ph.D., Toxicology, Texas A&M University
- B.Sc., Pharmacology, University of Alberta
1 Practicing through a professional corporation.
- Member of the Canadian Bar Association and the Ontario Bar Association
- Member of the Intellectual Property Institute of Canada (IPIC)
- Member of the South Asian Bar Association
- Former Chair of the IPIC Forums & Seminars Committee
- Former Chair Toronto Intellectual Property Group
1 Practicing through a professional corporation.
- Listed in Chambers and Partners – Intellectual Property: Litigation (2022-2024)
- Listed in Best Lawyers in Canada in Intellectual Property Law (2016-2023)
- Listed in Managing IP – IP Stars (2016-2023)
- Listed in Managing IP – Top 250 Women in IP globally (2016-2017, 2022-2023)
- Listed in IAM Patent 1000 (2017-2023)
- Listed in Expert Guides – Women in Business Law (Patents) (2017-2023)
- Listed in Lexpert Special Edition on Technology and Health (2022-2023) and Litigation (2022-2023)
- Listed in LMS Life Sciences as a Leading Lawyer (2022/2023)
- Who's Who Legal: Life Sciences (2018-2023), Thought Leaders Global Elite (2021-2023)
- WIPR Leaders (2018-2023)
1 Practicing through a professional corporation.
- Bristol-Myers v. Pharmascience, 2021 FC 1
- Janssen Inc v. Pharmascience, 2021 FC 7
- Valeant Canda v. Ranbaxy Pharmaceuticals, 2018 FC 847
- Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals, 2014 FCA 17
- Shire Canada Inc. v. Cobalt Pharmaceuticals, 2015 FC 458
- Pharmascience Inc. v. Pfizer Canada Inc., 2011 FCA 102
- Teva Canada Limited v. Canada (Health), 2011 FC 507
- Alcon Canada Inc. v. Cobalt Pharmaceuticals, 2014 FC 149
- Laboratoires Servier et.al. v. Apotex Inc., 2008 FC 825
1 Practicing through a professional corporation.